Anzeige
Mehr »
Lynx Broker
Login
Donnerstag, 22.08.2019 Börsentäglich über 12.000 News von 607 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Zur alten Webversion

WKN: 860736 ISIN: US2045121074 Ticker-Symbol: N/A 
1-Jahres-Chart
CALMARE THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
CALMARE THERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur CALMARE THERAPEUTICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
19.07.CALMARE THERAPEUTICS Inc - 8-K, Current Report-
10.06.CALMARE THERAPEUTICS Inc - 8-K, Current Report-
03.06.Calmare Therapeutics Incorporated: Calmare Therapeutics Receives Favorable Decision From The U.S. Court Of Appeals For The Second Circuit10GEOMC's Petition for Rehearing Denied $10.4 Million Judgment Against Calmare Therapeutics Vacated FAIRFIELD, CT / ACCESSWIRE / June 3, 2019 / Calmare Therapeutics Incorporated, (OTC PINK: CTTC), the...
► Artikel lesen
03.06.CALMARE THERAPEUTICS Inc - 8-K, Current Report-
25.03.Calmare Therapeutics Incorporated: Calmare Therapeutics Receives Two Favorable Rulings In Delaware Chancery Court7FAIRFIELD, CT / ACCESSWIRE / March 25, 2019 / Calmare Therapeutics Incorporated, (OTC PINK: CTTC), the pain mitigation company ("Calmare" or the "Company"), announced today that, on March 15, 2019,...
► Artikel lesen
25.03.CALMARE THERAPEUTICS Inc - 8-K, Current Report-
19.03.Calmare Therapeutics Incorporated: Calmare Therapeutics Has $10.4 Million Judgment Vacated by The U.S. Court of Appeals for The Second Circuit6FAIRFIELD, CT / ACCESSWIRE / March 19, 2019 / Calmare Therapeutics Incorporated, (OTC PINK: CTTC) ('CTI'), the pain mitigation company ('Calmare'), had a $10.4 million judgment vacated by the United...
► Artikel lesen
18.03.CALMARE THERAPEUTICS Inc - 8-K, Current Report-
8 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1